EWG News 29.39 09/08/2014 04:49:10 Germany Index MSCI Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Germany Index MSCI Ishares (EWG) 29.39 $EWG

'Fast Money' Recap: Apple Under $100? Now What?
at The Street - Thu Sep 04, 4:00AM CDT
The trading panel discussed Apple stock slide and whether to buy Yum! Brands or McDonald's.

Watch for iShares MSCI Germany Index Fund to Potentially Pullback After Gaining 1.38% Yesterday
Comtex SmarTrend(R) - Wed Sep 03, 4:18PM CDT
iShares MSCI Germany Index Fund (AMEX:EWG) traded in a range yesterday that spanned from a low of $29.28 to a high of $29.44. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $29.03 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

5 European ETFs to Watch on Russia Food Ban - ETF News And Commentary
Zacks Research Staff - ZACKS - Wed Aug 27, 9:03AM CDT
These European ETFs could be impacted by the Russian ban of certain food imports from the West.

Look for Shares of iShares MSCI Germany Index Fund to Potentially Pullback after Yesterday's 1.04% Rise
Comtex SmarTrend(R) - Mon Aug 25, 4:36PM CDT
iShares MSCI Germany Index Fund (AMEX:EWG) traded in a range yesterday that spanned from a low of $28.94 to a high of $29.19. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $29.04 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

'Fast Money' Recap: Will Apple Shares Pull Back?
at The Street - Sat Aug 23, 4:00AM CDT
The trading panel discussed the company's all-time high and how to trade following Janet Yellen's Jackson Hole comments.

Where Will Europe ETFs Go After Portugal Banking Woes? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 5:00AM CDT
Investors could look at some of the top ranked European ETFs which have declined recently due to Portugal banking woes.

iShares MSCI Germany Index Fund Falls 1.23% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Aug 07, 4:10PM CDT
iShares MSCI Germany Index Fund (AMEX:EWG) traded in a range yesterday that spanned from a low of $27.91 to a high of $28.45. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $28.08 on volume of 7.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.58%, iShares MSCI Germany Index Fund Offers Investors Better Value
Comtex SmarTrend(R) - Fri Aug 01, 4:29PM CDT
iShares MSCI Germany Index Fund (AMEX:EWG) traded in a range yesterday that spanned from a low of $28.58 to a high of $29.00. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $29.10 on volume of 5.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Noteworthy ETF Outflows: EWG
ETFChannel.com - Fri Aug 01, 11:36AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI Germany ETF where we have detected an approximate $87.7 million dollar outflow -- that's a 1.9% decrease...

Brazilian Investors Avenge Germany's World Cup Win
at Investor's Business Daily - Tue Jul 29, 5:49PM CDT
Germany very publicly trounced Brazil during the World Cup semi-finals. More quietly, Brazilian investors have pounded their German counterparts since the start of this year. Sao Paulo's benchmark index, the Bovespa, has climbed 11% year to date. The...

'Fast Money' Recap: Are Investors Finally Fed Up With Amazon?
at The Street - Sat Jul 26, 4:00AM CDT
The trading panel was not impressed by Amazon's earnings but El Pollo Loco is a great story.

'Fast Money' Recap: Fear Gauge Retreats but Be Cautious
at The Street - Sat Jul 19, 4:00AM CDT
The trading panel discussed Friday's rally and what they'll be buying and selling next week.

'Fast Money' Recap: Trading on Geopolitical Tensions
at The Street - Fri Jul 18, 4:00AM CDT
The trading panel discussed the downing of a Malaysian airliner over Ukraine, Israel's ground war in Gaza and whether to invest in Google and IBM.

The Zacks Analyst Blog Highlights: Alcoa, iShares MSCI Brazil Capped ETF, iShares MSCI Germany ETF, Global X FTSE Argentina 20 ETF and iShares MSCI Netherlands ETF
PR Newswire - Wed Jul 09, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Alcoa (NYSE:AA-Free Report), iShares MSCI Brazil Capped ETF (AMEX:EWZ-Free Report),iShares MSCI Germany ETF (AMEX:EWG-Free Report), Global X FTSE Argentina 20 ETF (AMEX:ARGT-Free Report)andiShares MSCI Netherlands ETF (AMEX:EWN-Free Report).

2014 World Cup Semi-Finals: ETF Edition - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 11:00AM CDT
There are only four countries left for the 2014 FIFA World Cup, find out which ETF proxy prevails.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading